Login / Signup

Targeting interleukin-5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms.

Emanual MaverakisAntonio Ji-XuMarie-Charlotte Brüggen
Published in: Allergy (2022)
Keyphrases
  • cancer therapy
  • emergency department
  • drug induced
  • drug delivery
  • adverse drug